Cibenzoline

Cibenzoline is a Class I antiarrhythmic agent used in the treatment of cardiac arrhythmia. It is a sodium channel blocker, which works by slowing the rapid heartbeats associated with arrhythmia.

Mechanism of Action

Cibenzoline, like other Class I antiarrhythmic agents, works by blocking the sodium channels in the heart. This slows the rapid heartbeats associated with arrhythmia, allowing the heart to beat more regularly and efficiently.

Indications

Cibenzoline is indicated for the treatment of various types of cardiac arrhythmias, including supraventricular tachycardia, ventricular tachycardia, and atrial fibrillation. It may also be used in the management of premature ventricular contractions.

Side Effects

Common side effects of Cibenzoline include dizziness, nausea, vomiting, and fatigue. Less common side effects may include chest pain, shortness of breath, and palpitations.

Contraindications

Cibenzoline is contraindicated in patients with heart block, sick sinus syndrome, or cardiogenic shock. It should also be used with caution in patients with liver disease or kidney disease, as these conditions can affect the metabolism and excretion of the drug.

Interactions

Cibenzoline may interact with other medications, including other antiarrhythmic agents, beta blockers, and calcium channel blockers. These interactions can increase the risk of side effects and should be monitored closely.

See Also

• Antiarrhythmic agent
• Cardiac arrhythmia
• Sodium channel blocker

This article is a stub related to pharmacology. You can help WikiMD by expanding it!